Suppr超能文献

墨西哥成年 COVID-19 患者中糖尿病与死亡率之间关联的年龄效应。

The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico.

机构信息

Institute for Globally Distributed Open Research and Education (IGDORE), Los Angeles, CA, USA.

Hospital Nacional Docente Madre Niño San Bartolomé, Lima, Peru.

出版信息

Sci Rep. 2021 Apr 16;11(1):8386. doi: 10.1038/s41598-021-88014-z.

Abstract

Diabetes is associated with severe COVID-19 and mortality. The aim of the present study was to determine the effect of age on the association between diabetes and mortality in patients with laboratory-confirmed COVID-19 in Mexico. This retrospective cohort study involved patients aged 20 years or older with symptoms of viral respiratory disease who were screened for SARS-CoV-2 infection across the System of Epidemiological Surveillance of Viral Respiratory Disease in Mexico from January 1 through November 4, 2020. Cox proportional-hazard regression was used to calculate the hazard ratio for 28-day mortality and its 95% confidence interval (CI). Among 757,210 patients with COVID-19 (outpatients and inpatients), 120,476 (16%) had diabetes and 80,616 died. Among 878,840 patients without COVID-19 (those who tested negative for SARS-CoV-2 infection), 88,235 (10.0%) had diabetes and 20,134 died. Among patients with COVID-19, diabetes was associated with a hazard ratio for death of 1.49 (95% CI 1.47-1.52), adjusting for age, sex, smoking habit, obesity, hypertension, immunodeficiency, and cardiovascular, pulmonary, and chronic renal disease. The strength of the association decreased with age (trend test: P = 0.004). For example, the adjusted hazard ratio for death was 3.12 (95% CI 2.86-3.40) for patients 20-39 years of age; in contrast, the adjusted hazard ratio of death for patients 80 years of age or older was 1.11 (95% CI 1.06-1.16). The adjusted hazard ratios were 1.66 (95% CI 1.58-1.74) in outpatients and 1.14 (95% CI 1.12-1.16) in inpatients. In hospitalized patients 80 years of age or older, no association was observed between diabetes and COVID-19-related mortality (adjusted hazard ratio: 1.03; 95% CI 0.98-1.08). Among patients without COVID-19, the adjusted hazard ratio for death was 1.78 (95% CI 1.73-1.84). In conclusion, in adult patients with COVID-19 in Mexico, the risk of death associated with diabetes decreased with age. No association between diabetes and mortality was observed among inpatients 80 years of age or older. Our findings should be verified in other populations.

摘要

糖尿病与严重的 COVID-19 和死亡率相关。本研究的目的是确定年龄对墨西哥实验室确诊 COVID-19 患者中糖尿病与死亡率之间关联的影响。这项回顾性队列研究涉及年龄在 20 岁及以上、有病毒性呼吸道疾病症状的患者,他们在 2020 年 1 月 1 日至 11 月 4 日期间通过墨西哥病毒呼吸道疾病流行病学监测系统接受了 SARS-CoV-2 感染筛查。使用 Cox 比例风险回归计算 28 天死亡率及其 95%置信区间(CI)的风险比。在 757210 例 COVID-19(门诊和住院患者)中,有 120476 例(16%)患有糖尿病,80616 例死亡。在 878840 例未感染 COVID-19(SARS-CoV-2 感染检测呈阴性的患者)中,有 88235 例(10.0%)患有糖尿病,20134 例死亡。在 COVID-19 患者中,糖尿病与死亡的风险比为 1.49(95%CI 1.47-1.52),调整年龄、性别、吸烟习惯、肥胖、高血压、免疫缺陷以及心血管、肺部和慢性肾病因素后。这种关联的强度随年龄的增长而减弱(趋势检验:P=0.004)。例如,20-39 岁患者的死亡调整风险比为 3.12(95%CI 2.86-3.40);相比之下,80 岁及以上患者的死亡风险比为 1.11(95%CI 1.06-1.16)。门诊患者的调整风险比为 1.66(95%CI 1.58-1.74),住院患者为 1.14(95%CI 1.12-1.16)。在 80 岁及以上的住院患者中,糖尿病与 COVID-19 相关死亡率之间没有关联(调整后的风险比:1.03;95%CI 0.98-1.08)。在未感染 COVID-19 的患者中,死亡的调整风险比为 1.78(95%CI 1.73-1.84)。总之,在墨西哥患有 COVID-19 的成年患者中,糖尿病相关死亡风险随年龄的增长而降低。在 80 岁及以上的住院患者中,糖尿病与死亡率之间没有关联。我们的研究结果需要在其他人群中进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ee/8052362/4c985e1e9eba/41598_2021_88014_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验